Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Substance Use: Research and Treatment is Scopus-indexed (Q2, CiteScore 5), WoS ESCI. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 2976-8357Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 119 / 466 | 74th | Q2 |
| Psychiatry and Mental Health | 187 / 580 | 67th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2024–present, best quartile Q2, CiteScore 5.
Substance Use: Research and Treatment is Q2 in Medicine (miscellaneous) (rank 119 of 466) and Q2 in Psychiatry and Mental Health (rank 187 of 580), by CiteScore 2025.
Substance Use: Research and Treatment is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5, which places it in quartile Q2 at the 74th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.965, quartile Q1, with an H-index of 38.
Substance Use: Research and Treatment is published by SAGE Publications Ltd. Its ISSN is 2976-8357.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Substance Use: Research and Treatment has an h-index of 5 and a 2-year mean of 1.27 citations per paper (OpenAlex). Its Scopus CiteScore is 5, quartile Q2. On 2-year citations it ranks #234 of 451 Scopus journals in Medicine (miscellaneous).
Substance Use: Research and Treatment published 32 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 91 research articles (2024–2026), authors are most often from United States (69.2%), Canada (6%) and Ethiopia (2.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.